{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:16:33Z","timestamp":1793693793962,"version":"4.5.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI083281"],"award-info":[{"award-number":["R01 AI083281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.antiviral.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T12:41:38Z","timestamp":1518784898000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replication"],"prefix":"10.1016","volume":"153","author":[{"given":"Kristen N.","family":"Westdorp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott S.","family":"Terhune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.02.014_bib1","first-page":"263","article-title":"Modulation of host cell stress responses by human cytomegalovirus","volume":"325","author":"Alwine","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-016-0653-5","article-title":"Cytomegalovirus vaccines: current status and future prospects","volume":"76","author":"Anderholm","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2018.02.014_bib3","doi-asserted-by":"crossref","first-page":"29593","DOI":"10.1074\/jbc.M202312200","article-title":"Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase. Importance of the P+5 position","volume":"277","author":"Baek","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.02.014_bib4","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.00986-15","article-title":"Antagonistic relationship between human cytomegalovirus pUL27 and pUL97 activities during infection","volume":"89","author":"Bigley","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib5","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action","volume":"46","author":"Biron","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.014_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital human cytomegalovirus infection and the enigma of maternal immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","article-title":"Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53","volume":"22","author":"Bywater","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.antiviral.2018.02.014_bib8","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/JVI.75.8.3613-3625.2001","article-title":"Degradation of p21cip1 in cells productively infected with human cytomegalovirus","volume":"75","author":"Chen","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2018.02.014_bib10","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Drygin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2018.02.014_bib11","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase","volume":"85","author":"Goldner","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e32834cfb58","article-title":"The biology of cytomegalovirus drug resistance","volume":"24","author":"Hakki","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.014_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/nucl.32235","article-title":"Nucleolar stress with and without p53","volume":"5","author":"James","year":"2014","journal-title":"Nucleus Austin Tex."},{"key":"10.1016\/j.antiviral.2018.02.014_bib14","doi-asserted-by":"crossref","first-page":"W676","DOI":"10.1093\/nar\/gkl253","article-title":"QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences","volume":"34","author":"Kikin","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.02.014_bib15","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.014_bib16","series-title":"Fields Virology","first-page":"1960","article-title":"Cytomegaloviruses","author":"Mocarski","year":"2013"},{"key":"10.1016\/j.antiviral.2018.02.014_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005717","article-title":"Efficacy and mechanism of action of low dose emetine against human cytomegalovirus","volume":"12","author":"Mukhopadhyay","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.02.014_bib18","doi-asserted-by":"crossref","first-page":"14976","DOI":"10.1073\/pnas.2136652100","article-title":"Coding potential of laboratory and clinical strains of human cytomegalovirus","volume":"100","author":"Murphy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.02.014_bib19","doi-asserted-by":"crossref","first-page":"49800","DOI":"10.18632\/oncotarget.10452","article-title":"Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM\/ATR signaling","volume":"7","author":"Quin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2018.02.014_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chom.2011.01.006","article-title":"Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest","volume":"9","author":"Reitsma","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2018.02.014_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1099\/vir.0.83286-0","article-title":"Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40\/E","volume":"89","author":"Sinzger","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00593-17","article-title":"Cytomegalovirus late protein pUL31 alters Pre-rRNA expression and nuclear organization during infection","volume":"91","author":"Westdorp","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.014_bib23","doi-asserted-by":"crossref","first-page":"14432","DOI":"10.1038\/ncomms14432","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T21:31:43Z","timestamp":1535059903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217305478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":23,"alternative-id":["S0166354217305478"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replication","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}